CHOLESTYRAMINE FOR ORAL SUSPENSI. Key specifications include physical_form: POWDER, primary_container_type: CAN, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 378.000 GRAMS G, active_medicament_medicinal_strength: 4.000 GRAMS CHOLESTYRAMINE RESIN, ANHYDROUS EQUIVALENT G, part_name_assigned_by_controlling_agency: CHOLESTYRAMINE FOR ORAL SUSPENSION USP 4GM EQUIV/DOSE 378GM. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-00-368-5919, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | POWDER |
| primary_container_type | CAN |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 378.000 GRAMS G |
| active_medicament_medicinal_strength | 4.000 GRAMS CHOLESTYRAMINE RESIN, ANHYDROUS EQUIVALENT G |
| part_name_assigned_by_controlling_agency | CHOLESTYRAMINE FOR ORAL SUSPENSION USP 4GM EQUIV/DOSE 378GM |
| NSN | 6505-00-368-5919 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PHYSICAL FORM | POWDER |
| PRIMARY CONTAINER TYPE | CAN |
| PRIMARY CONTAINER CONTENT QUANTITY | 378.000 GRAMS G |